3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol

This compound is a synthetic small molecule belonging to the class of trisubstituted thiazoles. It has been studied as an experimental agent and is not approved for clinical use. The structure features a thiazole ring substituted with two methyl groups at positions 2 and 4 and linked via a pyrimidine moiety to an aminophenolic group. Literature and patent data indicate that compounds of this type are investigated as inhibitors of cyclin-dependent kinases (CDKs), particularly CDK2/cyclin E and CDK4/cyclin D1 complexes. These kinases play key roles in cell cycle regulation; thus, inhibition may result in antiproliferative effects relevant for cancer therapy. However, there are no approved indications or clinical trials reported for this specific compound[1][2][6].

Other names

3-{[4-(dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino}phenol3-(4-(2,4-dimethyl-thiazol-5-Yl)-pyrimidin-2-Ylamino)-phenol3-{[4-(2,4-dimethyl–1,3-thiazol–5–yl)pyrimidin–2–yl]amino}phenol3-{[4-(diméthyl–1,3-thiazol–5–yl)–2-pyrimidinyl]amino}phénol